|
Research & Development
|
14.11M | 18.06M |
|
Share-based Compensation (IS)
|
1.47M | 1.17M |
|
Selling, General & Administrative
|
5.31M | 5.77M |
|
Operating Expenses
|
19.42M | 23.83M |
|
Operating Income
|
-19.42M | -23.83M |
|
EBIT
|
-19.42M | -23.83M |
|
Other Non Operating Income
|
1.00M | -1.91M |
|
Non Operating Income
|
-0.08M | -0.19M |
|
EBT
|
-19.72M | -27.86M |
|
Profit After Tax
|
-19.13M | -26.95M |
|
Income from Continuing Operations
|
-19.72M | -27.86M |
|
Consolidated Net Income
|
-19.72M | -27.86M |
|
Income towards Parent Company
|
-19.72M | -27.86M |
|
Net Income towards Common Stockholders
|
-19.72M | -27.86M |
|
EPS (Basic)
|
-0.33 | -0.33 |
|
EPS (Weighted Average and Diluted)
|
-0.33 | -0.33 |
|
Shares Outstanding (Weighted Average)
|
| 68.32M |
|
EBITDA
|
-19.42M | -23.83M |